Conjunctival melanoma. What has changed over 55 years?
- Authors: Grishina EE1, Andreichenko AM1, Fedotova OF1
-
Affiliations:
- Ophthalmological Clinical Hospital of Moscow Health Department, Moscow, Russia
- Issue: Vol 94, No 4 (2013)
- Pages: 586-588
- Section: Actual problems of ophthalmology
- URL: https://journals.rcsi.science/kazanmedj/article/view/1977
- DOI: https://doi.org/10.17816/KMJ1977
- ID: 1977
Cite item
Full Text
Abstract
Aim. To study the changes of conjunctival melanoma clinical characteristics over 55 years according to data of oncological department of Moscow ophthalmological clinical hospital. Methods. The change of conjunctival melanoma clinical characteristics over 55 years was studied. Two patient groups were compared. Group I included patients who were treated and observed in Moscow ophthalmological clinical hospital in 1956-1970, group II included patients who were treated and observed in Moscow ophthalmological clinical hospital in 1982-2013. Medical charts (i.e., case records, clinical histories, pathohistological reports, questionnaires of patients who received beta-applicator therapy etc.) were analyzed. Results. Over 55 years, the prevalence of conjunctival melanoma did not increase. In recent years, conjunctival melanoma has been diagnosed mainly in older patients, however, sex distribution has not changed. Nowadays, small size tumors dominated in primary patients while tumor pigmentation remain unchanged. Tumors localized at corneal limbus and bulbar conjunctiva, i.e. at palpebral fissure, as well as at lacrimal caruncle and plica semilunaris, were still the most frequent, which is associated with intensive insolation of these areas. Total 10-year survival rate in conjunctival melanoma patients was high (>80%) over the whole period. Conclusion. Small size tumors predominance indicates that conjunctival pigment tumors diagnostics improved over recent decade due to ophthalmic equipment development, oncological suspicion increase and the possibility to refer patients to specialized ophthalmic oncological centers.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
E E Grishina
Ophthalmological Clinical Hospital of Moscow Health Department, Moscow, Russia
Email: eyelena@mail.ru
A M Andreichenko
Ophthalmological Clinical Hospital of Moscow Health Department, Moscow, Russia
O F Fedotova
Ophthalmological Clinical Hospital of Moscow Health Department, Moscow, Russia
References
- Бровкина А.Ф., Вальский В.В., Гусев Г.А. и др. Офтальмоонкология. Руководство для врачей. - М.: Медицина, 2002. - 424 с.
- Choi J., Kim M., Park H.S., Lee S.Y. Clinical follow-up of conjunctival malignant melanoma // Korean J. Ophthalmol. - 2005. - Vol. 19. - P. 91-95.
- Colby K.A., Nagel D.S. Conjunctival melanoma arising from diffuse primary acquired melanosis in young black woman // Cornea. - 2005. - Vol. 24. - P. 352-355.
- Harooni H., Schoenfield L.R., Singh A.D. Current appraisal of conjunctival melanocytic tumors: classification and treatment // Future Oncol. - 2011. - Vol. 7. - P. 435-446.
- Keijser S., Missotten G.S., Bonfrer J.M. et al. Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions // Br. J. Ophtalmol. - 2006. - Vol. 90. - P. 213-217.
- Kimura K., Usui Y., Goto H. Clinical findings and prognosis of 11 cases of conjunctival malignant melanoma // Nihon Ganka Gakkai Zasshi. - 2012. - Vol. 116. - P. 503-509.
- Kovacević D., Lukanović-Primc K., Markusić V. et al. Conjunctival amelanotic melanoma - a case report // Coll. Antropol. - 2011. - Vol. 35, suppl. 2. - P. 295-297.
- Rudkin A.K., Dodd T., Muecke J.S. The differential diagnosis of localised amelanotic limbal lesions: a review of 162 consecutive excisions // Br. J. Ophthalmol. - 2011. - Vol. 95. - P. 50-54.
- Shields C.L. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients // Tr. Am. Ophth. Soc. - 2000. - Vol. 98. - P. 471-492.
- Shields J.A., Shields C.L., Mashayekhi А. et al. Primary acquired melanosis of the conjunctiva: experience with 311 eyes // Trans. Am. Ophthalmol. Soc. - 2007. - Vol. 105. - P. 61-72.
- Triay E., Bergman L., Nilsson B. et al. Time trends in the incidence of conjunctival melanoma in Sweden // Br. J. Ophthalmol. - 2009. - Vol. 93. - P. 1524-1528.
- Uçakhan-Gündüz Ö., Gündüz K., Karsloğlu M.Z. Corneal melanoma: report of three cases // Eye Contact Lens. - 2012. - Vol. 38. - P. 341-344.
- Yousef Y.A., Finger P.T. Predictive value of the se-venth edition American Joint Committee on Cancer staging system for conjunctivalmelanoma // Arch. Ophthalmol. - 2012. - Vol. 130. - P. 599-606.
- Zembowicz A., Mandal R.V., Choopong P. Melanocytic lesions of the conjunctiva // Arch. Pathol. Lab. Med. - 2010. - Vol. 134. - P. 1785-1792.
- Zoroquiain P., Fernandes B.F., González S. et al. p16ink4a expression in benign and malignant melanocytic conjunctival lesions // Int. J. Surg. Pathol. - 2012. - Vol. 20. - P. 240-245.